Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 4,063 put options on the stock. This is an increase of ...
4d
Assenagon Asset Management S.A. raised its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 12.4% during the 4th quarter, HoldingsChannel reports. The fund owned 238,522 shares of ...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a $3 billion market cap pharmaceutical company specializing in the development of therapeutic drugs, announced today the departure of its Chief Commercial ...
TipRanks on MSN6d
Xenon Pharmaceuticals’ CCO Departure and Consultancy RoleChristopher Von Seggern stepped down as Chief Commercial Officer of Xenon Pharmaceuticals Inc. and departed from the company. In connection with his departure ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
For the mountaineers, climbing the peaks of Mount Everest is the piece de resistance of their careers. What a lot of people don't realize is that accomplishing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback